AU2003232834A1 - Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid - Google Patents

Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid

Info

Publication number
AU2003232834A1
AU2003232834A1 AU2003232834A AU2003232834A AU2003232834A1 AU 2003232834 A1 AU2003232834 A1 AU 2003232834A1 AU 2003232834 A AU2003232834 A AU 2003232834A AU 2003232834 A AU2003232834 A AU 2003232834A AU 2003232834 A1 AU2003232834 A1 AU 2003232834A1
Authority
AU
Australia
Prior art keywords
chain
long
pharmaceutical composition
fatty acid
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003232834A
Inventor
Thomas Bachleithner-Hofmann
Erich Roth
Sandra Andrea Sturlan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Austria GmbH
Original Assignee
Fresenius Kabi Austria GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Austria GmbH filed Critical Fresenius Kabi Austria GmbH
Publication of AU2003232834A1 publication Critical patent/AU2003232834A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003232834A 2002-05-31 2003-05-27 Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid Abandoned AU2003232834A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10224171.6 2002-05-31
DE10224171A DE10224171A1 (en) 2002-05-31 2002-05-31 A pharmaceutical composition comprising arsenic trioxide and at least one long chain polyunsaturated fatty acid
PCT/EP2003/005577 WO2003101470A1 (en) 2002-05-31 2003-05-27 Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid

Publications (1)

Publication Number Publication Date
AU2003232834A1 true AU2003232834A1 (en) 2003-12-19

Family

ID=29557431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003232834A Abandoned AU2003232834A1 (en) 2002-05-31 2003-05-27 Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid

Country Status (3)

Country Link
AU (1) AU2003232834A1 (en)
DE (1) DE10224171A1 (en)
WO (1) WO2003101470A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425833A1 (en) 2010-09-03 2012-03-07 Fresenius Kabi Deutschland GmbH Intravenous application of fish oils / DHA + EPA before or at the beginning of chemotherapy

Also Published As

Publication number Publication date
WO2003101470A1 (en) 2003-12-11
DE10224171A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
PL357924A1 (en) Composition for peroxidisingly colouring creatinefibre, containing etherocarboxylic acid, oxyalkylenated polymer capable to form associates and non-saturated fatty acid
EP1801096B8 (en) Polyglycerol fatty acid ester and composition containing same
HUP0303354A3 (en) 6-alpha, 9-alpha-difluoro-17-alpha-(2-furanylcarboxyl)oxy-11-betha-hydroxy-16-alpha-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester with anti-inflammatory effect, process for its preparation and pahrmaceutical composition containing it
EP1709952B8 (en) Composition containing polyglycerol/medium-chain fatty acid ester
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
AU2003201693A1 (en) Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
IL161431A0 (en) beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AU2002300678A1 (en) Cosmetic compositions containing a methacrylic acid copolymer and an oil, and uses thereof
AU2002355012A1 (en) Microcapsules and oral compositions containing the same
EP1344835A3 (en) Real-time nucleic acid detection processes and compositions
AU2003245308A1 (en) Fatty acid desaturases from fungi
AU2003265328A1 (en) Novel microencapsulation processes and compositions for electrophoretic displays
AU2002363361A1 (en) Pharmaceutical compositions containing oxybutynin
AU2003220786A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
IL217317A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same and uses thereof
AU2003271510A1 (en) Formulation of oral compositions comprising arsenic trioxide and methods of use thereof
AU5394100A (en) Fatty acid elongation genes and uses thereof
IL157649A0 (en) Adenosine derivatives having an acetylene group in the 4' position, pharmaceutical compositions containing them and use thereof in decreasing plasma free fatty acid concentration
AU2001250933A1 (en) Chitosan formulation with azelaic acid and other actives for the treatment of acne
AU2003290006A1 (en) Sunflower oil, seeds and plants with modified fatty acid distribution in the triacylglycerol molecule
AU2003232834A1 (en) Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid
AU2002253265A1 (en) Composition for enteral nutrition comprising fibres
IL158293A (en) Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
AU2003257780A1 (en) Pharmaceutical compositions containing polydatin or its salts and their application
AU2002361096A1 (en) Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase